We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Simulations Plus
SLP
$371M
| $2.84M | ﹤0.01% |
58,534
-1,727
| -3% | -$101K |
|
|
ADAM
2177
Adamas Trust
ADAM
$883M
| $2.84M | ﹤0.01% |
303,238
-9,167
| -3% | -$104K |
|
2178
Interface
TILE
$2.22B
| $2.82M | ﹤0.01% |
314,049
-11,536
| -4% | -$140K |
|
|
HONE
2179
DELISTED
HarborOne Bancorp
HONE
| $2.82M | ﹤0.01% |
210,306
-8,461
| -4% | -$119K |
|
|
CINC
2180
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $2.82M | ﹤0.01% |
85,880
+34,277
| +66% | +$969K |
|
2181
Abercrombie & Fitch
ANF
$5B
| $2.82M | ﹤0.01% |
181,123
-5,347
| -3% | -$92.3K |
|
2182
Treace Medical Concepts
TMCI
$309M
| $2.82M | ﹤0.01% |
127,634
-767
| -0.6% | -$14.8K |
|
|
AGNT
2183
AGNT Inc
AGNT
$734M
| $2.82M | ﹤0.01% |
251,157
+33,027
| +15% | +$460K |
|
2184
A10 Networks
ATEN
$1.95B
| $2.81M | ﹤0.01% |
211,541
-389,801
| -65% | -$5.55M |
|
2185
Rocket Lab Corp
RKLB
$51.8B
| $2.81M | ﹤0.01% |
689,635
+64,001
| +10% | +$316K |
|
2186
Titan International
TWI
$475M
| $2.81M | ﹤0.01% |
231,228
-24,158
| -9% | -$347K |
|
|
KAMN
2187
DELISTED
Kaman Corp
KAMN
| $2.81M | ﹤0.01% |
100,482
-30,763
| -23% | -$960K |
|
|
PRSU
2188
Pursuit Attractions and Hospitality Inc
PRSU
$1.25B
| $2.81M | ﹤0.01% |
88,853
+12,774
| +17% | +$446K |
|
2189
Anavex Life Sciences
AVXL
$310M
| $2.8M | ﹤0.01% |
271,455
-3,575
| -1% | -$37.7K |
|
2190
The Greenbrier Companies
GBX
$1.46B
| $2.79M | ﹤0.01% |
115,146
-3,112
| -3% | -$93.8K |
|
|
AVTA
2191
DELISTED
Avantax, Inc. Common Stock
AVTA
| $2.79M | ﹤0.01% |
144,354
-3,127
| -2% | -$62.9K |
|
|
VMEO
2192
DELISTED
Vimeo
VMEO
| $2.79M | ﹤0.01% |
697,077
-47,019
| -6% | -$278K |
|
|
UMH
2193
UMH Properties
UMH
$1.36B
| $2.79M | ﹤0.01% |
172,447
-28,172
| -14% | -$529K |
|
|
LGF.B
2194
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $2.78M | ﹤0.01% |
399,837
-135,173
| -25% | -$1.23M |
|
|
RETA
2195
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $2.77M | ﹤0.01% |
110,433
-3,213
| -3% | -$89K |
|
2196
Byline Bancorp
BY
$1.76B
| $2.76M | ﹤0.01% |
136,127
-1,978
| -1% | -$45.3K |
|
2197
Liberty Media Series A
FWONA
$23.6B
| $2.75M | ﹤0.01% |
54,789
-5,476
| -9% | -$305K |
|
2198
Beyond Meat
BYND
$277M
| $2.75M | ﹤0.01% |
194,117
-11,494
| -6% | -$317K |
|
2199
Ardmore Shipping
ASC
$683M
| $2.75M | ﹤0.01% |
301,205
+166,144
| +123% | +$1.48M |
|
2200
1st Source
SRCE
$2.12B
| $2.75M | ﹤0.01% |
59,320
-1,463
| -2% | -$69.5K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.